NO142260C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater

Info

Publication number
NO142260C
NO142260C NO740405A NO740405A NO142260C NO 142260 C NO142260 C NO 142260C NO 740405 A NO740405 A NO 740405A NO 740405 A NO740405 A NO 740405A NO 142260 C NO142260 C NO 142260C
Authority
NO
Norway
Prior art keywords
tienotriazolodiazepine
derivatives
preparation
therapeutically active
analogy procedure
Prior art date
Application number
NO740405A
Other languages
English (en)
Norwegian (no)
Other versions
NO740405L (no
NO142260B (no
Inventor
Joseph Hellerbach
Paul Zeller
Dieter Binder
Otto Hromatka
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO740405L publication Critical patent/NO740405L/no
Publication of NO142260B publication Critical patent/NO142260B/no
Publication of NO142260C publication Critical patent/NO142260C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
NO740405A 1973-02-08 1974-02-07 Analogifremgangsmaate ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater NO142260C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH179973A CH584223A5 (pl) 1973-02-08 1973-02-08

Publications (3)

Publication Number Publication Date
NO740405L NO740405L (no) 1974-08-09
NO142260B NO142260B (no) 1980-04-14
NO142260C true NO142260C (no) 1980-07-23

Family

ID=4218866

Family Applications (1)

Application Number Title Priority Date Filing Date
NO740405A NO142260C (no) 1973-02-08 1974-02-07 Analogifremgangsmaate ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater

Country Status (24)

Country Link
JP (1) JPS5833234B2 (pl)
AR (2) AR203188A1 (pl)
AT (1) AT343118B (pl)
BE (1) BE810705A (pl)
CA (1) CA1049009A (pl)
CH (1) CH584223A5 (pl)
DD (1) DD112454A5 (pl)
DE (1) DE2405682C3 (pl)
DK (1) DK137679B (pl)
FI (1) FI58129C (pl)
FR (1) FR2217007B1 (pl)
GB (2) GB1456161A (pl)
HU (2) HU170423B (pl)
IE (1) IE38883B1 (pl)
IL (1) IL44095A (pl)
LU (1) LU69338A1 (pl)
NL (1) NL174045C (pl)
NO (1) NO142260C (pl)
PH (1) PH12303A (pl)
PL (3) PL96107B1 (pl)
SE (1) SE416399B (pl)
SU (3) SU715028A3 (pl)
YU (1) YU39716B (pl)
ZA (1) ZA74472B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT338799B (de) * 1974-03-02 1977-09-12 Boehringer Sohn Ingelheim Verfahren zur herstellung neuer substituierter 6-aryl-4h-s-triazolo-(3,4c)-thieno-(2,3e)-1,4-diazepine und ihrer salze
DE2533924C3 (de) * 1975-07-30 1979-05-03 C.H. Boehringer Sohn, 6507 Ingelheim Verfahren zur Herstellung von 6- Aryl-4H-striazolo [3,4-c] thieno [2,3-e] 1,4-diazepinen
DE2531678C3 (de) * 1975-07-16 1979-06-28 C.H. Boehringer Sohn, 6507 Ingelheim Thieno [2,3e] triazole [3,4c] 5,6-dihydro-l,4diazepine und Verfahren zu ihrer Herstellung
DE2708121A1 (de) * 1977-02-25 1978-09-07 Boehringer Sohn Ingelheim Triazolo-thieno-diazepin-l-one, verfahren zu ihrer herstellung und arzneimittel
FI63033C (fi) * 1977-07-21 1983-04-11 Boehringer Sohn Ingelheim Foerfarande foer framstaellning av anxiolytiska tranquilliserande sedativa och/eller neuroleptiska substituerade 1-piperazinyl-4h-s-triazolo(3,4-c)tieno(2,3-e)-1,4-diazepiner
DE3502392A1 (de) * 1985-01-25 1986-07-31 Boehringer Ingelheim KG, 6507 Ingelheim Neue thieno-triazolo-1,4-diazepino-2- carbonsaeureamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen
ES2037013T3 (es) * 1986-01-21 1993-06-16 Boehringer Ingelheim Kg Procedimiento para preparar tieno-1,4-diazepinas.
JP2582225B2 (ja) * 1994-04-15 1997-02-19 ナショナル住宅産業株式会社 建 具
WO1995032963A1 (fr) * 1994-06-01 1995-12-07 Yoshitomi Pharmaceutical Industries, Ltd. Compose de thienylazole et compose de thienotriazolodiazepine
DE69625696T2 (de) * 1995-09-09 2003-10-16 F. Hoffmann-La Roche Ag, Basel Verwendung eines thienotriazoldiazepins zur erhöhung des apolopoproteins a-i niveaus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904641A (en) * 1971-06-18 1975-09-09 Yoshitomi Pharmaceutical Triazolothienodiazepine compounds

Also Published As

Publication number Publication date
GB1456161A (en) 1976-11-17
FI58129B (fi) 1980-08-29
IL44095A (en) 1979-03-12
AR217034A1 (es) 1980-02-29
DE2405682C3 (de) 1981-03-12
NL174045C (nl) 1984-04-16
SU747429A4 (ru) 1980-07-23
FR2217007A1 (pl) 1974-09-06
BE810705A (fr) 1974-08-07
NL174045B (nl) 1983-11-16
JPS5833234B2 (ja) 1983-07-18
IL44095A0 (en) 1974-05-16
NO740405L (no) 1974-08-09
IE38883B1 (en) 1978-06-21
JPS49102698A (pl) 1974-09-27
CA1049009A (en) 1979-02-20
ZA74472B (en) 1974-11-27
AU6485574A (en) 1975-07-24
HU173741B (hu) 1979-08-28
DK137679C (pl) 1978-09-25
FI58129C (fi) 1980-12-10
SU715028A3 (ru) 1980-02-05
YU39716B (en) 1985-04-30
LU69338A1 (pl) 1975-12-09
CH584223A5 (pl) 1977-01-31
HU170423B (pl) 1977-06-28
NL7401117A (pl) 1974-08-12
SU1060115A3 (ru) 1983-12-07
PL97275B1 (pl) 1978-02-28
SE416399B (sv) 1980-12-22
DE2405682A1 (de) 1974-08-15
DE2405682B2 (de) 1980-07-17
GB1456162A (en) 1976-11-17
AT343118B (de) 1978-05-10
YU22874A (en) 1982-06-30
PL97304B1 (pl) 1978-02-28
DK137679B (da) 1978-04-17
DD112454A5 (pl) 1975-04-12
PH12303A (en) 1979-01-16
IE38883L (en) 1974-08-08
NO142260B (no) 1980-04-14
PL96107B1 (pl) 1977-12-31
ATA96474A (de) 1977-09-15
FR2217007B1 (pl) 1978-02-03
AR203188A1 (es) 1975-08-22

Similar Documents

Publication Publication Date Title
NO141407C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive etylenderivater
NO145576C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive penicillinderivater
NO142441C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme karboksylsyrederivater
NO143940C (no) Fremgangsmaate ved fremstilling av alfa-l-aspartyl-l-fenyl-alaninalkylestere
NO147450C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolonderivater
NO142304C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-acyl-4-oxo-hexahydro-4h-pyrazino-(2,1-a)-isokinolin-derivater
NO149281C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater
NO147109C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive diazepin-derivater
NO151040C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner
NO140058C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater
NO146095C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinazolin-derivater
NO142894C (no) Fremgangsmaate ved fremstilling av polyethylenterefthalatfilm
NO142303C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme oksazolderivater
NO140057C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive alfa-aryl-4-substituerte piperidinoalkanol-derivater
NO146359C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater
NO140597C (no) Analogifremgangsmaate ved fremstillingen av terapeutisk aktive 8-azapurin-6-on-derivater
NO741125A (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive pyrido-pyrimidin-derivater.
NO141755C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme dotriacontapeptidamider
NO142260C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater
NO143064C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner
NO140670C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolodiazepinderivater
NO144110C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5:6-benzo-4-pyron-derivater
NO147485C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 8-aminomethylisoflavonderivater
NO143499C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanderivater
NO147754C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme cefemderivater.